• en
  • ru
Change language

Our products

Boldaloin®

tablets, OTC drug

Boldaloin® is produced in the form of round, biconvex tablets, of beige to grey color with marble pattern. 1 tablet contains 3.60 – 4.40 mg of anthranoid compounds converted into alloin.

The drug is traditionally applied as an agent stimulating secretion of bile and gastric juice and regulating frequency of defecation. The drug efficiency in the above mentioned indications is based exclusively on long period of application and experience.

Indications for application
Traditionally used in case of indigestion accompanied by sensation of fullness in the abdomen, bile and gastric juice secretion disorders, mild spastic gastro-intestinal disorders. Traditionally applied for regulation of defecation frequency (mild constipation related to change of diet or residence place).

As a cholepoietic preparation and to stimulate secretion of gastric juice: adults orally 1 tablet 3 times a day, children over 12 years of age and elderly individuals 1 to 2 tablets a day.

As a mild agent regulating defecation: 1 to 3 tablets as a single dose, in the evening.

In case of taking higher than recommended dose of Boldaloin®
In case of serious overdose, many times exceeding the recommended doses (taking of dozen or so tablets for several days), nausea, vomiting, diarrhea, electrolyte disorders, dehydration, cardiac rhythm disorders and increase of menstrual bleeding may occur. It is necessary to take orally about 10 g of activated carbon and consult a physician in case of overdose.

In case of long application of high doses of aloe extract, albuminuria, hematuria and harmless accumulation of pigment in the intestinal mucosa (pseudomelanosis coli) occur, which usually disappears after withdrawal of the drug.

 

Do not use the drug in case of hypersensitivity to any of the preparation components, liver cirrhosis, occlusion of bile ducts and alimentary tract, stenosis of alimentary tract, intestinal atonia (loss of normal smooth muscle tonus), appendicitis, inflammatory diseases of large intestine (e.g. Crohn’s disease, ulcerative colon inflammation), stomach aches of unclear etiology, renal insufficiency, disorders of water-electrolyte balance.

Observe special caution while applying Boldaloin®, because:
It is not recommended to use the drug for longer than 7 to 10 days without physician’s consultation because of the possibility of weakening of intestinal peristalsis in case of long term use.
In case of cholelithiasis, apply the drug exclusively after consultation with a physician.
Observe special care while applying simultaneously with diuretic drugs.
Avoid using during menstruation.
Do not administer to children younger that 12 years of age.

Application of Boldaloin® in children
Do not administer Boldaloin® to children younger than 12 years of age.

Application of Boldaloin® during pregnancy and breast feeding
It is not recommended to use during pregnancy and breast feeding.
Possible application of the preparation is admissible only with a physician’s approval.

Driving of vehicles and operation of moving mechanisms
No adverse influence of Boldaloin® on the ability to driver vehicles and operate moving mechanisms has been found.

Important information concerning components of the product of Boldaloin®

Use of other drugs
In large doses and in combination with diuretics, adrenocorticosteroids and licorice root, it may potentially cause hypokaliemia (decrease of potassium level). It is not recommended to apply Boldaloin® simultaneously with anti-arrhythmic drugs and laxatives.

Usually no undesired effects are observed. Sporadically possible vomiting, diarrhea, hypokaliemia (potassium level decrease), biliary colic and allergic reactions to the preparation components.
Withdraw the drug in case of undesired symptoms.
Change of urine color may appear in rare cases.
In case of other undesired effects, not mentioned here, it is necessary to inform a physician.

Store at the temperature not exceeding 25°C.
Store the drug out of reach and sight of children.
Do not use the drug after expiry date stated on the package.

1 tablet contains

Active substances:
Aloe extractum siccum (2:1), extractant: purified water 23.6 mg
Boldinum 1.0 mg

Auxiliary substances :
potato starch, saccharose, Arabic gum, glycerol, talc, magnesium stearate
1 tablet contains 3.60 – 4.40 mg of anthranoid compounds converted into alloin.

Packaging: 30 tablets.


Explore plant: